Floatz logo

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER

Sciatica

Johns Hopkins Universityprotein_peptidePhase 2/3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
Lidocaine
C.L.A.Vleggeert-Lankamp
Phase 4BBB
Dexasone
University of Miami
Phase 4BBB
Nepenthe
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
Prednisone
Kaiser Permanente
Phase 3BB

View all 44 →

Same molecule, other indications

1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER is also rated in:

psoriasisDormant
BBB
Indicative · Phase 4
76 / 100
View asset →
skin carcinomaDormant
BB
Indicative · Phase 4
67 / 100
View asset →
cancer of unknown primary siteDormant
B
Indicative · Phase 3
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →